Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

AKT1 (PKB alpha) Recombinant Human Protein Non-distribution product as customer accommodation.

AKT1 (PKB alpha) Recombinant Human Protein

$433.00

Specifications

Accession Number NP_005154
Common Name AKT1 (PKB alpha) Recombinant Human Protein
Expression System Baculovirus
Gene Alias AKT1 (PKB alpha)
Molecular Weight 59.1kDa
View More Specs

Products 1
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
P2999 Non-distribution product as customer accommodation. View Documents LIFE TECHNOLOGIES
P2999
10μg Each for $433.00
Add to cart
 
Description

Description

AKT1 (PKB alpha) is a serine⁄threonine kinase that regulates cell survival. The activated enzyme inhibits apoptosis and stimulates cell cycle progression by phosphorylating numerous targets in various cell types, including cancer cells.
Specifications

Specifications

NP_005154
Baculovirus
59.1kDa
1 Each
90% by SDS-PAGE
–80°C
Human
AKT1 (PKB alpha) Recombinant Human Protein
AKT1 (PKB alpha)
AKT1 (PKB alpha) Recombinant Human Protein
AKT1 (PKB alpha) Recombinant Human Protein
For research use only. Not for use in diagnostic procedures
Kinase assay
His Tag

For Research Use Only. Not for use in diagnostic procedures.

Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit